November is the Pancreatic Cancer Awareness month and November 21st is World Pancreatic Cancer day. We, the Pancreatobiliary Pathology Society, support the mission to raise awareness and inspire action on this day. We send our support to the survivors, their families and to everyone who has lost a loved one to this deadly disease. We also reiterate our dedication to improve the clinical practice and management of pancreatic cancer and to foster tissue-based research.
Cystic and Intraductal Neoplasms of the Pancreatobiliary Tract When: February 29, 2020. 7-10PM Location: Los Angeles Convention Center
Moderators: Martha Bishop Pitman Deepti Dhall
Speakers: Jin-Young Jang: Management Algorithms for Pancreatic Cysts and Intraductal Neoplasms: The Surgeon’s Perspective Michelle D. Reid: Cytologic Assessment of Cystic/Intraductal Lesions of the Pancreatobiliary Tract Aatur D. Singhi: Preoperative Molecular Assessment of Pancreatic Cysts and Intraductal Lesions David S. Klimstra: Mucinous Cystic and Intraductal Neoplasms of the Pancreatobiliary Tract Irene Esposito: Non-mucinous Cystic Lesions of the Pancreas
Brief overview of what is being presented/discussed (this will also be shown in the Annual Meeting Program Book):
Despite numerous advances in the field, the diagnosis, classification, grading, and management of cystic and intraductal lesions of the pancreatobiliary tract remain controversial. Additionally, recently described entities such as intraductal tubulopapillary neoplasm (ITPN) and intraductal papillary neoplasm of the bile duct (IPNB) remain diagnostically challenging, and their prognostic implications are poorly understood. The mission of the Pancreatobiliary Pathology Society is to educate surgical and cytopathologists on the importance of the advances in this complex area and will hopefully transform the way we practice pancreatobiliary pathology. The Education Committee, in consultation with Society officers, determined the title, contents, and speakers of this companion meeting.
The chosen topics represent a 360-degree expert evaluation of cystic and intraductal pancreatobiliary lesions in the step-wise manner in which they are often encountered, from the surgeon’s perspective, to their cytomorphologic and molecular characteristics, as well as their histomorphology.
Dear Pancreatobiliary Pathology Society (PBPS) members and other interested parties in the pancreatobiliary pathology community,
PBPS is seeking enthusiastic volunteers for Case of the Quarter Subcommittee positions.
Applicants need to be active members in (or they can join) the PBPS. The subcommittee will have 4 members. Term for all members is 2 years. Each member will generate a case report to be published on the website once a year.
If you are interested in, please send an email, along with your CV, to Dr. Olca Basturk (email@example.com) by April 12, 2019. Applications will be reviewed by PBPS Executive Committee and chosen applicants will be informed via e-mail and will be posted in our website (http://www.pbpath.org/) no later than April 30, 2019.
It’s March, which means the 2019 annual USCAP meeting is upon us! Please join us on Saturday March 16th for our Companion Society Meeting: “Challenging Topics in Pancreatic Neoplasia: I: An Update on Non-ductal Neoplasms and II: Approach to Neo-adjuvant Treated Ductal Adenocarcinoma.” Our Education Committee has created an informative two-part session that will first cover non-ductal neoplasms of the pancreas followed by the pathologic evaluation of treated pancreatic cancer that will include an update about our Neo-adjuvant Therapy Working Group. The Education Committee has also been busy reviewing the 15 abstracts they received for the Pancreatobiliary Pathology Society Abstract Award, and the winner will be announced at our annual Business Meeting, which will immediately follow the Companion Society session from 9:45 pm – 10:00 pm. For those who are unable to attend, please check our website after the meeting.
Our society has been productive over the past several months in other areas as well. The next case of the quarter will soon be released – keep an eye out for it on our website! Our bimonthly journal watch nicely highlights pertinent publications involving the pancreatobiliary tract. Both of these activities are now perks of membership. If you are not an active member, please join or renew your membership online! If you are a new member, welcome! In addition to the Neo-adjuvant Therapy Working Group, we have two other active Working Groups: The Grossing Working Group is in the process of writing a manuscript and the Cytology Working Group has been formed and is gathering data.
Our society would not be a success if it were not for the tireless efforts of our members. I would like to recognize the following members who have been making an impact in our society: Olca Basturk, who was instrumental in organizing this year’s companion session; Serdar Balci for publishing the bimonthly journal watch; Jiaqi Shi and Michelle Reid for contributing the cases of the quarter; Mabel Ko for managing our website; and the members of the Executive Committee, Grace Kim, David Klimstra, David Lewin, Volkan Adsay and Olca, for keeping everything on track and in order.
I am proud to be part of this international organization that strives to improve the clinical practice of pancreatobiliary pathology by providing a comfortable environment of team work and cooperation. An organization from which will sprout future leaders in the field of pancreatobiliary pathology.
Symposium Title: Challenging Topics in Pancreatic Neoplasia I: An Update on Non-ductal Neoplasms and II: Approach to Neo-adjuvant Treated Ductal Adenocarcinoma
Moderators: Giuseppe Zamboni, University of Verona and Aatur D. Singhi, University of Pittsburgh Medical Center
Part I: Non-ductal Neoplasms of the Pancreas
Laura Wood, Johns Hopkins Hospital: Pancreatic Neoplasms with Acinar Differentiation
Laura Tang, Memorial Sloan Kettering Cancer Center: Pancreatic Neuroendocrine Neoplasm – Landscape and Horizon
Stephano La Rosa, Lausanne University Hospital: Pancreatic solid pseudopapillary neoplasm – Key Histopathologic and Genetic Features
Part II: Neo-adjuvant Therapy in Pancreatic Ductal Adenocarcinoma
Huamin Wang, University of Texas MD Anderson Cancer Center: Pathologic Evaluation of Treated Pancreatic Ductal Adenocarcinoma and Its Clinical Implications
Pancreatobiliary Pathology Society Business Meeting 9:45 pm- 10:00 pm
We are pleased to announce that the Pancreatobiliary Pathology Society will be awarding a pathology trainee who is presenting an abstract (poster or platform) on the field of pancreatobiliary pathology at the annual meeting of the USCAP. The members of the education committee will evaluate each abstract based on originality, scientific merit and presentation and the winner will receive a $250 prize. Please remind/encourage your trainees to apply. Applicants do not need to be society member in order to apply.
The deadline for the Abstract Awards is January 30, 2019.
To submit an application, please email your abstract and the following information to our chair of education committee Dr. Olca Basturk (firstname.lastname@example.org)
Date/Time of Presentation:
Poster Number (if applicable):
November is the Pancreas Cancer Awareness month and November 15th is the World Pancreas Cancer day. We, the Pancreatobiliary Pathology Society, support the mission to raise awareness and inspire action on this day. We send our support to the survivors, their families and to everyone who has lost a loved one to this deadly disease. We also reiterate our dedication to improve the clinical practice and management of pancreatic cancer and to foster tissue-based research.
Neoadjuvant therapy is increasingly used for the treatment of pancreatic cancer. Resection specimens that have undergone such treatment pose substantial diagnostic, staging, prognostic and reporting challenges. These issues have been raised at past PBPS meetings as some of the more challenging areas in our field that require further standardization.
In order to address this, PBPS has created a new working group, the Neo-Adjuvant Therapy Working Group, whose role will be to tackle these issues. After reviewing the many highly qualified applicants for membership, we selected the following new members and look forward to learning from them.
Dr. Runjan Chetty from Toronto General Hospital, Canada
Dr. Huamin Wang from MD Anderson Cancer Center, USA
Daniela Allende from Cleveland Clinic, USA
Dr. Irene Esposito from Heinrich-Heine University of Duesseldorf, Germany
Dr. Mojgan Hosseini from University of California San Diego, USA
Dr. Yoko Matsuda from Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Japan
Pancreatobiliary Pathology Society Education Committee
Last year was a very productive year that culminated with our inaugural Companion Society Meeting at the annual USCAP meeting in Vancouver, Canada in March. I want to thank our speakers, Ralph Hruban, Olca Basturk, and Gunter Kloppel for their excellent educational talks, and Daniela Allende and Grace Kim for presenting a summary of the findings from the Grossing Working Group, our first active working group. I want to thank the audience for their attendance (and for not being distracted by the beautiful scenery that flanked one entire wall of the meeting room).
Members of all PBPS committees worked extremely hard over the past year not only to create a successful companion session, but to also strengthen existing and bring new activities to our young society. I’d like to recognize the following members who really made this past year a success: Olca Basturk, who was instrumental in organizing the companion session; Daniela Allende and Grace Kim, for their contributions to the companion session; Mabel Ko for creating, updating and managing our website; and David Lewin, for running the business meeting and keeping our finances in order.
I’d like to touch upon a few items that are currently in the PBPS pipeline:
The Grossing Working Group is in the process of converting their Companion Society meeting presentation into a manuscript.
I am honored to have been elected President of the PBPS and I am proud to carry on the tradition of fostering excellence and collaboration in education, research and the clinical practice of pancreatobiliary pathology around the world.